Affiner les résultats

Locally advanced/inflammatory breast cancers treated with intensive epirubicin-based neoadjuvant chemotherapy: are there molecular markers in the primary tumour that predict for 5-year clinical outcome?

Bonnefoi, H. ; Diebold-Berger, S. ; Therasse, P. ; Hamilton, A. ; van de Vijver, M. ; MacGrogan, G. ; Shepherd, L. ; Amaral, N. ; Duval, C. ; Drijkoningen, R. ; Larsimont, D. ; Piccart, M.

In: Annals of Oncology, 2003, vol. 14, no. 3, p. 406-413